Dose-dependent progression of multiple low-dose streptozotocin-induced diabetes in mice
Physiological Genomics · 01.09.2023 · 55 (9) · 381-391
DOI: 10.1152/physiolgenomics.00032.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Genomics, erschienen am 01.09.2023. Verfasst von Brandon M Bauer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular & Cellular Endocrinology, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope, Duarte, California, United Sta…. Hauptthemen laut MEDLINE: Islets of Langerhans, Insulin-Secreting Cells, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, Wanek Family Project to Cure Type 1 Diabetes.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study investigated the effects of different multiple low doses of streptozotocin (STZ), namely 35 and 55 mg/kg, on the onset and progression of diabetes in mice. Both doses are commonly used in research, and although both induced a loss of beta cell mass, they had distinct effects on whole glucose tolerance, beta cell function, and gene transcription. Mice treated with 55 mg/kg became rapidly glucose intolerant, whereas those treated with 35 mg/kg had a slower onset and remained glucose tolerant for up to a week before becoming equally glucose intolerant as the 55 mg/kg group. Beta cell mass loss was similar between the two groups, but the 35 mg/kg-treated mice had improved glucose-stimulated insulin secretion in gold-standard hyperglycemic clamp studies. Transcriptomic analysis revealed that the 55 mg/kg dose caused disruptions in nearly five times as many genes as the 35 mg/kg dose in isolated pancreatic islets. Pathways that were downregulated in both doses were more downregulated in the 55 mg/kg-treated mice, whereas pathways that were upregulated in both doses were more upregulated in the 35 mg/kg-treated mice. Moreover, we observed a differential downregulation in the 55 mg/kg-treated islets of beta cell characteristic pathways, such as exocytosis or hormone secretion. On the other hand, apoptosis was differentially upregulated in 35 mg/kg-treated islets, suggesting different transcriptional mechanisms in the onset of STZ-induced damage in the islets. This study demonstrates that the two STZ doses induce distinctly mechanistic progressions for the loss of functional beta cell mass.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular & Cellular Endocrinology, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope, Duarte, California, United States.
- Irell & Manella Graduate School of Biological Science, Beckman Research Institute, City of Hope, Duarte, California, United States.
- Integrative Genomics Core, Beckman Research Institute, City of Hope, Duarte, California, United States.
- Comprehensive Metabolic Phenotyping Core, Beckman Research Institute, City of Hope, Duarte, California, United States.
ORCID-Profile: Patrick T Fueger
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- Wanek Family Project to Cure Type 1 Diabetes
- HHS | National Institutes of Health
Zitieren
APA
Bauer, B. M., Bhattacharya, S., Bloom-Saldana, E., Irimia-Dominguez, J. M., & Fueger, P. T. (2023). Dose-dependent progression of multiple low-dose streptozotocin-induced diabetes in mice. Physiological Genomics, 55(9), 381-391. https://doi.org/10.1152/physiolgenomics.00032.2023
Vancouver
Bauer BM, Bhattacharya S, Bloom-Saldana E, Irimia-Dominguez JM, Fueger PT. Dose-dependent progression of multiple low-dose streptozotocin-induced diabetes in mice. Physiological Genomics. 2023;55(9):381-391. doi:10.1152/physiolgenomics.00032.2023
BibTeX
@article{Bauer2023,
author = {Bauer, Brandon M and Bhattacharya, Supriyo and Bloom-Saldana, Elizabeth and Irimia-Dominguez, Jose M and Fueger, Patrick T},
title = {Dose-dependent progression of multiple low-dose streptozotocin-induced diabetes in mice},
journal = {Physiological Genomics},
year = {2023},
volume = {55},
number = {9},
pages = {381--391},
doi = {10.1152/physiolgenomics.00032.2023}
}
EUVIMED